Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    November 2017
  1. FLORIJN BW, Bijkerk R, van der Veer E, van Zonneveld AJ, et al
    Gender and cardiovascular disease: Are sex-biased miRNA networks a driving force behind heart failure with preserved ejection fraction in women?
    Cardiovasc Res. 2017 Nov 24. pii: 4657087. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  2. RIPPLINGER CM
    From drugs to devices and back again: chemical vagal nerve stimulation for the treatment of heart failure.
    Cardiovasc Res. 2017;113:1270-1272.
    PubMed     Text format    


    July 2017
  3. FRASER AG, Gillebert TC, Leite-Moreira AF
    Ventricular-arterial coupling in heart failure with preserved ejection fraction: the devil is in the details.
    Cardiovasc Res. 2017;113:844-846.
    PubMed     Text format    


    June 2017
  4. SCHOBESBERGER S, Wright P, Tokar S, Bhargava A, et al
    T-tubule remodelling disturbs localized beta2-adrenergic signalling in rat ventricular myocytes during the progression of heart failure.
    Cardiovasc Res. 2017;113:770-782.
    PubMed     Text format     Abstract available


    May 2017
  5. ABDURRACHIM D, Nabben M, Hoerr V, Kuhlmann MT, et al
    Diabetic db/db mice do not develop heart failure upon pressure overload: A longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
    Cardiovasc Res. 2017 May 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. VILLALBA-ORERO M, Lopez-Olaneta MM, Gonzalez-Lopez E, Padron-Barthe L, et al
    Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice.
    Cardiovasc Res. 2017 May 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. GARROTT K, Dyavanapalli J, Cauley E, Kate Dwyer M, et al
    Chronic activation of hypothalamic oxytocin neurons improves cardiac function during left ventricular hypertrophy-induced heart failure.
    Cardiovasc Res. 2017 May 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. LI J, Yousefi K, Ding W, Singh J, et al
    Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
    Cardiovasc Res. 2017;113:633-643.
    PubMed     Text format     Abstract available


  9. NONHOFF J, Ricke-Hoch M, Mueller M, Stapel B, et al
    Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Cardiovasc Res. 2017;113:598-608.
    PubMed     Text format     Abstract available


    April 2017
  10. CROSSMAN DJ, Shen X, Jullig M, Munro M, et al
    Increased collagen within the transverse tubules in human heart failure.
    Cardiovasc Res. 2017 Apr 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. PEREZ DEL VILLAR C, Savvatis K, Lopez B, Kasner M, et al
    Impact of acute hypertension transients on diastolic function in patients with heart failure with preserved ejection fraction.
    Cardiovasc Res. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  12. SATO T, Sato C, Kadowaki A, Watanabe H, et al
    ELABELA - APJ axis protects from pressure overload heart failure and Angiotensin II-induced cardiac damage.
    Cardiovasc Res. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  13. LI J, Yousefi K, Ding W, Singh J, et al
    Osteopontin RNA Aptamer Can Prevent and Reverse Pressure Overload-Induced Heart Failure.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


  14. GRECO S, Zaccagnini G, Fuschi P, Voellenkle C, et al
    Increased Bace1-As Long Noncoding Rna And beta-Amyloid Levels In Heart Failure.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


  15. ELIA L, Quintavalle M, Condorelli G
    Circular RNAs and heart failure: new players for an old disease.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


    January 2017
  16. NONHOFF J, Ricke-Hoch M, Mueller M, Stapel B, et al
    Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Cardiovasc Res. 2017 Jan 20. pii: cvw245. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2016
  17. LI L, Li J, Drum BM, Chen Y, et al
    Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


    July 2016
  18. TAKADA S, Masaki Y, Kinugawa S, Matsumoto J, et al
    Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of GLP-1 receptor signaling.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  19. LIU L, An X, Li Z, Song Y, et al
    The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Cardiovasc Res. 2016;111:56-65.
    PubMed     Text format     Abstract available


  20. SCHEID LM, Mosqueira M, Hein S, Kossack M, et al
    Essential light chain S195 phosphorylation is required for cardiac adaptation under physical stress.
    Cardiovasc Res. 2016;111:44-55.
    PubMed     Text format     Abstract available


    June 2016
  21. BOOIJ HG, Yu H, de Boer RA, van de Kolk CW, et al
    Overexpression of A kinase interacting protein 1 attenuates myocardial ischemia / reperfusion injury, but does not influence heart failure development.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  22. HILLE S, Dierck F, Kuhl C, Sosna J, et al
    Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
    Cardiovasc Res. 2016;110:381-94.
    PubMed     Text format     Abstract available


    May 2016
  23. GOGIRAJU R, Schroeter MR, Bochenek ML, Hubert A, et al
    Endothelial Deletion of Protein Tyrosine Phosphatase-1B Protects Against Pressure Overload-Induced Heart Failure in Mice.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  24. KOOIJ V, Viswanathan MC, Lee DI, Rainer PP, et al
    Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy.
    Cardiovasc Res. 2016;110:238-48.
    PubMed     Text format     Abstract available


    March 2016
  25. MASSENGILL MT, Ashraf HM, Chowdhury RR, Chrzanowski SM, et al
    Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  26. BYRNE NJ, Levasseur J, Sung MM, Masson G, et al
    Normalization of Cardiac Substrate Utilization and Left Ventricular Hypertrophy Precede Functional Recovery in Heart Failure Regression.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  27. GOH KY, Qu J, Hong H, Liu T, et al
    Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes.
    Cardiovasc Res. 2016;109:79-89.
    PubMed     Text format     Abstract available


    December 2015
  28. KUMAGAI S, Nakayama H, Fujimoto M, Honda H, et al
    Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


    November 2015
  29. MAACK C
    Orphaned mitochondria in heart failure.
    Cardiovasc Res. 2015.
    PubMed     Text format    


    September 2015
  30. LUCAS A, Mialet-Perez J, Daviaud D, Parini A, et al
    Gadd45gamma regulates cardiomyocytes death and post-myocardial infarction left ventricular remodelling.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


    June 2015
  31. FERT-BOBER J, Giles JT, Holewinski RJ, Kirk JA, et al
    Citrullination of myofilament proteins in heart failure.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


  32. HAUBNER BJ, Moik D, Schuetz T, Reiner MF, et al
    In vivo cardiac role of migfilin during experimental pressure overload.
    Cardiovasc Res. 2015;106:398-407.
    PubMed     Text format     Abstract available


    May 2015
  33. YABLUCHANSKIY A, Ma Y, Lindsey ML
    Syndecan-4: a novel regulator of collagen synthesis and deposition in the pressure-overloaded myocardium.
    Cardiovasc Res. 2015;106:178-9.
    PubMed     Text format    


  34. SEYMOUR AM, Giles L, Ball V, Miller JJ, et al
    In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy.
    Cardiovasc Res. 2015;106:249-60.
    PubMed     Text format     Abstract available


  35. HERUM KM, Lunde IG, Skrbic B, Louch WE, et al
    Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.
    Cardiovasc Res. 2015;106:217-26.
    PubMed     Text format     Abstract available


    April 2015
  36. DI LISA F, Itoh N
    Cardiac Fgf21 synthesis and release: an autocrine loop for boosting up antioxidant defenses in failing hearts.
    Cardiovasc Res. 2015;106:1-3.
    PubMed     Text format    


  37. SKRBIC B, Engebretsen KV, Strand ME, Lunde IG, et al
    Lack of collagen VIII reduces fibrosis and promotes early mortality and cardiac dilatation in pressure overload in mice.
    Cardiovasc Res. 2015;106:32-42.
    PubMed     Text format     Abstract available


  38. PLANAVILA A, Redondo-Angulo I, Ribas F, Garrabou G, et al
    Fibroblast growth factor 21 protects the heart from oxidative stress.
    Cardiovasc Res. 2015;106:19-31.
    PubMed     Text format     Abstract available


    March 2015
  39. XU X, Tan X, Tampe B, Nyamsuren G, et al
    Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis.
    Cardiovasc Res. 2015;105:279-91.
    PubMed     Text format     Abstract available


    January 2015
  40. BOSSUYT J
    Nuclear remodelling: a consequence of nucleocytoplasmic traffic run amok?
    Cardiovasc Res. 2015;105:6-7.
    PubMed     Text format    


  41. SEIDEL M, Thomas NL, Williams AJ, Lai FA, et al
    Dantrolene rescues aberrant N-terminus intersubunit interactions in mutant pro-arrhythmic cardiac ryanodine receptors.
    Cardiovasc Res. 2015;105:118-28.
    PubMed     Text format     Abstract available


  42. CHAHINE MN, Mioulane M, Sikkel MB, O'Gara P, et al
    Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts.
    Cardiovasc Res. 2015;105:31-43.
    PubMed     Text format     Abstract available


    October 2014
  43. BANDARU S, Gronros J, Redfors B, Cil C, et al
    Deficiency of filamin A in endothelial cells impairs left ventricular remodeling after myocardial infarction.
    Cardiovasc Res. 2014.
    PubMed     Text format     Abstract available


    July 2014
  44. WESTERMANN D, Heymans S
    Fibrosis or hypertrophy: let TIMPs decide.
    Cardiovasc Res. 2014;103:196-7.
    PubMed     Text format    


  45. FAN D, Takawale A, Basu R, Patel V, et al
    Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Cardiovasc Res. 2014;103:268-80.
    PubMed     Text format     Abstract available


  46. ZHU W, Zhang W, Shou W, Field LJ, et al
    P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.
    Cardiovasc Res. 2014;103:81-9.
    PubMed     Text format     Abstract available


  47. MATHIYALAGAN P, Keating ST, Du XJ, El-Osta A, et al
    Chromatin modifications remodel cardiac gene expression.
    Cardiovasc Res. 2014;103:7-16.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: